Organization of the human intestine at single-cell resolution
- PMID: 37468586
- PMCID: PMC10356619
- DOI: 10.1038/s41586-023-05915-x
Organization of the human intestine at single-cell resolution
Abstract
The intestine is a complex organ that promotes digestion, extracts nutrients, participates in immune surveillance, maintains critical symbiotic relationships with microbiota and affects overall health1. The intesting has a length of over nine metres, along which there are differences in structure and function2. The localization of individual cell types, cell type development trajectories and detailed cell transcriptional programs probably drive these differences in function. Here, to better understand these differences, we evaluated the organization of single cells using multiplexed imaging and single-nucleus RNA and open chromatin assays across eight different intestinal sites from nine donors. Through systematic analyses, we find cell compositions that differ substantially across regions of the intestine and demonstrate the complexity of epithelial subtypes, and find that the same cell types are organized into distinct neighbourhoods and communities, highlighting distinct immunological niches that are present in the intestine. We also map gene regulatory differences in these cells that are suggestive of a regulatory differentiation cascade, and associate intestinal disease heritability with specific cell types. These results describe the complexity of the cell composition, regulation and organization for this organ, and serve as an important reference map for understanding human biology and disease.
© 2023. The Author(s).
Conflict of interest statement
C.M.S. is a scientific advisor to, has stock options in and has received research funding from Enable Medicine. 10X Genomics holds the license to patents in which W.J.G. is listed as an inventor. W.J.G. is an equity holder of 10X Genomics, and a co-founder of Protillion Biosciences. W.J.G. consults for Guardant Health, Quantapore, Protillion Biosciences, Ultima Genomics, Lamar Health, and Erdio Biosciences. M.P.S. is a cofounder and an advisory board member of Personalis, Qbio, January AI, Mirvie, Filtricine, Fodsel, Protos, RTHM, Marble Therapeutics and Crosshair Therapeutics. G.P.N. received research grants from Pfizer, Vaxart, Celgene and Juno Therapeutics; and has equity in and is a scientific advisory board member of Akoya Biosciences. The other authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
